• Explore /
  • Poster
  • / Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study.

Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study.

Abstract Poster

Authors

Mark Fleming

Mark T. Fleming

Virginia Oncology Associates, Norfolk, VA

Mark T. Fleming , Dana E. Rathkopf , Jackie Gibbons , Amy C. Peterson , Alison Hannah , David Forer , Howard I. Scher , Michael J. Morris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT01565928

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 63)

DOI

10.1200/jco.2013.31.6_suppl.63

Abstract #

63

Poster Bd #

D18

Abstract Disclosures

Similar Posters

First Author: Andrew J. Armstrong

First Author: Kunal Desai

Poster

2023 ASCO Genitourinary Cancers Symposium

Androgen receptor (AR) mutations in men with metastatic castration-resistant prostate cancer (mCRPC): Incidence and natural history.

Androgen receptor (AR) mutations in men with metastatic castration-resistant prostate cancer (mCRPC): Incidence and natural history.

First Author: Alice Bernard-Tessier

First Author: Arpit Rao